Israel’s BrainStorm, together with Canadian company Octane Biotech, has built a bioreactor for commercial production of the stem cells used as a basis for the company’s treatment for ALCS. The ability to multiply stem cells is critical for the treatment’s success.
http://www.globes.co.il/en/article-brainstorm-cell-to-get-5m-from-brazilian-health-ministry-1000957966